Longeveron LLC
Price & Volume
Stats
See more52W Range | $0.77-$6.40 |
Market Cap | $23.1M |
Shares Short | 586,064 |
Financials
See moreRevenue (12 Mos) | $1.8M |
Revenue Growth (YoY) | 415.3% |
Gross Profit (12 Mos) | $1.3M |
Diluted EPS | -$5.62 |
News
See moreYahoo Finance • yesterday
Longeveron® to Report Full Year 2024 Financial Results and Host Conference Call on February 28, 2025
Yahoo Finance • 4 days ago
Presenting on the Emerging Growth Conference 79 Day 2 on February 19 Register Now
Yahoo Finance • 4 days ago
Longeveron® Announces World Health Organization Approval of “laromestrocel” as International Non-proprietary Name for Stem Cell Therapy Lomecel-B™
Yahoo Finance • 8 days ago
Longeveron to Present at the Emerging Growth Virtual Conference on February 19, 2025
About
CEO | Mr. Mohamed Wa'el Ahmed Hashad M.B.A. |
Address | Life Science & Technology Park, Miami, FL, United States, 33136 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 23 |
